Enliven Therapeutics (ELVN) Stock Price & Financial Analysis
Enliven Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Enliven Therapeutics
What is the current stock price for ELVN?
As of the latest trading session, ELVN stock trades at $45.10. The 52-week range is $14.79–$48.53, with a day range of $44.22–$45.72.
What is the P/E ratio for ELVN?
The P/E ratio (Price-to-Earnings) for ELVN is shown in the Key Statistics section. This valuation metric helps compare Enliven Therapeutics, Inc. to industry peers.
Does ELVN pay dividends?
Enliven Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ELVN?
Based on 9 analysts, the consensus for ELVN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ELVN?
Enliven Therapeutics's market capitalization is $2.83B, classifying it as a mid-cap company. Enliven Therapeutics operates in the Healthcare sector within the Biotechnology industry.